Expert Ratings For iRhythm Technologies
Portfolio Pulse from Benzinga Insights
Over the past three months, 9 analysts have shared their ratings on iRhythm Technologies (NASDAQ:IRTC), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has decreased by 13.12% to $120. Analysts have lowered their price targets, reflecting a cautious outlook. iRhythm Technologies, a digital healthcare company, has shown a 19.27% revenue growth but faces challenges with high debt and low ROE.
August 22, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have mixed sentiments on iRhythm Technologies with a lowered average price target of $120, reflecting a cautious outlook. Despite a 19.27% revenue growth, the company faces challenges with high debt and low ROE.
The article highlights a decrease in the average price target for IRTC, indicating a cautious outlook from analysts. Despite positive revenue growth, the company's high debt and low ROE present challenges, likely leading to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100